Often characterized by involuntary motor or vocal tics, Tourette syndrome typically appears in childhood and affects up to ...
By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.
The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients.
Baylen Dupree is saying “hell no” to a potential treatment for her Tourette syndrome. In PEOPLE's exclusive look at the ...
Tourette syndrome (TS) is clinically significant because it is much more common than previously thought, is easily misdiagnosed, and is often associated with significant comorbidity ...
Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Medical Center have been recognized by the ...